The Effect of Gliatamin (Chonline Alphoscerate) on Depressive Mood in Type 2 Diabetes Patients

This trial tests whether a supplement called choline alphoscerate (Gliatamin) can improve mild to moderate depressive mood in people aged 50 and older who have type 2 diabetes, since depression is more common in people with diabetes and can worsen overall health. **You may be eligible if...** - You are 50 or older with type 2 diabetes - Your blood sugar (HbA1c) is 10.0% or below (reasonably controlled) - You have mild to moderate depressive symptoms (BDI score between 10 and 29) - You are willing to use contraception if you are of childbearing age **You may NOT be eligible if...** - You have type 1 diabetes, gestational diabetes, or another type of secondary diabetes - You are currently taking antidepressant medications or medications for dementia - You have severe depression (BDI score of 30 or above) or an uncontrolled psychiatric disorder - You have serious liver disease, kidney failure, or chronic pancreatitis - You are HIV positive - You have a history of alcohol or drug abuse in the past 3 months - You are pregnant or breastfeeding - You have a known allergy to the study medication Talk to your doctor to see if this trial is right for you.